Pharmacological Blockade of Protease-Activated Receptor 2 Improves Airway Remodeling and Lung Inflammation in Experimental Allergic Asthma. Braz. J. Pharm. Sci. 2023, 58. https://doi.org/10.1590/s2175-97902022e201089.